Skip to main content
SpringerLink
Log in

DMARDs, splenectomy or colony-stimulating factors for neutropenia in Felty’s syndrome?

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pixley JS, Patchin GM. Felty’s syndrome: risks and benefits of treatment with haemopoietic growth factors. BioDrugs 1997 May; 7(5): 356–65

    Article  PubMed  CAS  Google Scholar 

  2. Disorders of the immune system, connective tissue and joints. In: Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 1652

  3. Rosenstein ED, Kramer N. Felty’s and pseudo-Felty’s syndromes. Semin Arthritis Rheum 1991 Dec; 129–42

    Google Scholar 

  4. Breedveld FC, Fibbe WE, Hermans J, et al. Factors influencing the incidence of infections in Felty’s syndrome. Arch Intern Med 1987; 147: 915–20

    Article  PubMed  CAS  Google Scholar 

  5. Pinals RS. Felty’s syndrome. In Kelly WN, Harris ED Jr, Reddy S, et al., editors. Textbook of rheumatology. 3rd ed. Philadelphia: W.B. Saunders Company, 1989: 924–30

    Google Scholar 

  6. British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 384–6

  7. Physicians GenRx. St Louis, Missouri: Mosby-Year Book, Inc., 1997: II–899–904, II-1863-7

  8. Krishnaswamy G, Odern C, Chi DS, et al. Resolution of the neutropenia of Felty’s syndrome by long term administration of recombinant granulocyte stimulating factor. J Rheumatol 1996; 23: 763–5

    PubMed  CAS  Google Scholar 

  9. Wandt H, Seifert M, Falge C, et al. Long-term correction of neutropenia in Felty’s syndrome with granulocyte colony-stimulating factor. Ann Hematol 1993; 66: 265–6

    Article  PubMed  CAS  Google Scholar 

  10. Pixley JS, Yoneda KY, Manalo PB. Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty’s syndrome. Am J Hematol 1993; 43: 304–6

    Article  PubMed  CAS  Google Scholar 

  11. Choi V, Mant M, Arron S. Treatment of refractory Felty’s syndrome with G-CSF and cyclophosphamide. Arthritis Rheum 1992; 32 Suppl.: 340

    Google Scholar 

  12. Lyman GH, Lyman CG, Sanderson RA, et al. Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy. J Natl Cancer Inst 1993; 85: 488–93

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

DMARDs, splenectomy or colony-stimulating factors for neutropenia in Felty’s syndrome?. Drugs Ther. Perspect 10, 6–9 (1997). https://doi.org/10.2165/00042310-199710060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710060-00002

Keywords

Search

Navigation